Lubiprostone

Advanced Rx Pharmacy of Tennessee, LLC🇺🇸 United States

FDA Page

Effective Date: Aug 16, 2023
Approval ID: 031170a4-5f7d-b371-e063-6394a90ae21d
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Lubiprostone 8mcg Capsules These highlights do not include all the information needed to use LUBIPROSTONE CAPSULES safely and effectively. See full prescribing information for LUBIPROSTONE CAPSULES. Lubiprostone capsules, for oral use Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.